Your fact-checks will appear here
Scientific society
Congress played a mixed, active role in both blocking and enabling portions of the Trump administration’s proposed cuts to cancer and biomedical research: courts and Democratic-led House actions helpe...
Clinical research testing ivermectin in cancer patients in 2024–2025 is sparse and concentrated mainly on triple‑negative breast cancer (TNBC) immunotherapy combinations; multiple reviews and preclini...
Reporting from 2024–2025 documents broad disruptions to NIH‑funded clinical research that included canceled and delayed cancer trials, but the publicly cited coverage and early studies enumerate count...
Published results for NCT05318469 are limited to conference abstracts and trial summaries that report tolerability and early activity signals: an ASCO/Journal of Clinical Oncology abstract states the ...
Federal cuts and policy shifts in 2025–2026 sharply narrowed the funding runway for cancer research, with reporting that NIH saw roughly $2.7 billion in grant cuts and a 31% year‑over‑year drop in can...
The Cancer Moonshot began under the Obama administration in 2016 with $1.8 billion in supplemental funding authorized by the 21st Century Cures Act and an initial $300 million first installment (Beau ...
About 2.04 million new cancer cases and roughly 618,120 cancer deaths are projected in the United States in 2025, meaning on average about 5,600 new diagnoses and 1,700 deaths per day . Lifetime and a...
Federal budget actions in 2025 have led to large, rapid reductions in NIH/NCI funding and related programs that press experts warn will hit specific cancer research activities hard: Democratic staff a...
Available U.S. and global reports agree that overall cancer incidence has been roughly stable or only modestly changing since 2020, but several specific cancers show clear upward trends—most notably c...
The principal reaction from cancer research advocacy groups to the Trump administration’s 2022 budget proposals for the National Cancer Institute was broadly critical and alarmed, with major organizat...
The available analyses present a split picture: several prominent cancer-research reports reviewed here do not mention the Trump administration’s specific role in the Childhood Cancer STAR Act, while ...
The available reporting shows the Trump administration’s NIH budget proposals and policy changes led to terminated or reduced grants affecting cancer research projects, disruptions to National Cancer ...